高级检索
当前位置: 首页 > 详情页

Phlorizin treatment attenuates obesity and related disorders through improving BAT thermogenesis

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]School of Chinese Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China [2]Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, Guangdong, China [3]Department of Hepatobiliary Surgery, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China
出处:
ISSN:

关键词: Obesity Phlorizin Brown adipose tissue Thermogenesis Tyk2/STAT3 UCP1

摘要:
Phlorizin is a member of the chalcone class of organic compounds and was originally extracted from apples. Intensive studies about phlorizin have been conducted. The aim of this study was to determine the therapeutic effects of phlorizin on diet-induced obese mice and to investigate the underlying mechanism. The results show that phlorizin has a beneficial impact on body weight and fat mass, alleviates lipid metabolism and glucose homeostasis. Brown adipose tissue (BAT) temperature was increased and morphological abnormalities were improved in obese mice after phlorizin treatment. Phlorizin activates the Tyk2/STAT3 signalling pathway, up-regulates the protein expression of UCP1, PPAR alpha, PPAR gamma, C/EBP beta and PRDM16, as well as increases BAT activity which contributes to antiobesity effects. This study suggests that phlorizin activates the Tyk2/STAT3 signalling pathway to induce thermogenesis in BAT and phlorizin has the therapeutic potential in treating obesity and comorbidity. (C) 2016 Elsevier Ltd. All rights reserved.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 2 区 工程技术
小类 | 2 区 食品科技
最新[2025]版:
大类 | 2 区 农林科学
小类 | 3 区 食品科技 4 区 营养学
JCR分区:
出版当年[2014]版:
Q1 FOOD SCIENCE & TECHNOLOGY
最新[2023]版:
Q2 FOOD SCIENCE & TECHNOLOGY Q2 NUTRITION & DIETETICS

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者机构: [1]School of Chinese Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
共同第一作者:
通讯作者:
通讯机构: [1]School of Chinese Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China [3]Department of Hepatobiliary Surgery, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China [*1]Department of Hepatobiliary Surgery,The Third Affiliated Hospital of Sun Yat-Sen University,Tianhe District, Guangzhou Tianhe Road 600, Guangzhou, Guangdong, China 510000. [*2]School of Chinese Pharmaceutical Science, Guangzhou University of Chinese Medicine, University Town, Guangzhou, Guangdong, China 510006
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2021 今日访问量:0 总访问量:646 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号